Webinar: Pneumatic Dry Granulation vs Wet Granulation - Could it be a Full Alternative?

Sponsored by: Atacama Labs

Focused on:

    Date: 27th October

    Days old: 5215

    Time: 14:00 BST

    Watch Now for FREE

    Can dry granulation be a full alternative to wet granulation?

    This in depth webinar will lead you through the technology, individual technological and commercial advantages of dry granulation technology known as PDG (pneumatic dry granulation) as well as its application fields and show detailed results for Paracetamol, Ibuprofen and Avicel developed with the technology. The advantages and solutions provided are adapted to an audience of galenic developers, production heads and life cycle managers working in the field of Rx/OTC/Generic pharmaceuticals and includes a stepwise business model for easy client access and testing.

    Presented by

    Dr Rob Lammens,

    CTO, Atacama Labs

    Dr. Robert Lammens is an experienced and acknowledged expert in the Pharmaceutical Technology, especially in dry granulation. He has received his Ph.D. in the field of Pharmaceutical Technology from the University of Leiden (the Netherlands) in 1981. After that he joined Bayer AG in Leverkusen , where he worked for 23 years mainly in the field of solid dosage forms. In addition to his new position as the CTO of Atacama Labs, he will continue as Senior Lecturer at the Department of Pharmaceutical Technology of University of Bonn, where he is coaching several Ph.D. projects in the field of granulation and tableting in close cooperation with the director of this department, Prof. Dr. Klaus-Jürgen Steffens. He is also an advisor to Gerteis Maschinen + Processengineering AG, the leading compactor vendor in the world technology‐wise.

    Steffen Mittwick,

    CEO, Atacama Labs

    Mr. Mittwich has worked in pharma industry since 1992 and has held several management positions within major European and international pharmaceutical companies, such as Sanofi-aventis, Aventis Pharma, and Pfizer. His latest position at Sanofi-aventis was Regional Business Director and CEO Winthrop Pharmaceuticals. Steffen Mittwich is Industrial Economics Engineer from the Technical University of Karlsruhe, Germany.

    Key Learning Objectives

    • With PDG technology you can effectively replace wet granulation by dry granulation with much lower costs (-30 to 40%) and no scale-up issues
    • PDG delivers both flowable and compactable granules
    • PDG can solve NCE development issues regarding drug loading, solubility, heat lability, hygrophilic / stability
    • It provides effective solutions for ODT forms as well as fix combinations

    Audience

    • Director Engineering - Purdue pharma
    • Director Oral Drug Delivery - Bend Research Inc.
    • General Manager - FR&D - Vivimed labs ltd
    • Head of Technology department - Alexandria
    • Process Development Project Leader - Bayer
    • Director Research Engineering - Purdue Pharma L.P.